Nano–bio interactions of upconversion nanoparticles at subcellular level: biodistribution and cytotoxicity

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Dan DT. Nanotechnology, nanoparticles and nanoscience: a new approach in chemistry and life sciences. J. Nanosci. Lett. 10(2), 17 (2020).
  CASGoogle Scholar
• 2. Nikalje AP. Nanotechnology and its applications in medicine. Med. Chem. 5(2), 81–89 (2015).
  Google Scholar
• 3. Contera S, Bernardino de la Serna J, Tetley TD. Biotechnology, nanotechnology and medicine. Emerg. Top Life Sci. 4(6), 551–554 (2020).
  Medline CASGoogle Scholar
• 4. Scheinberg DA, Grimm J, Heller DA, Stater EP, Bradbury M, McDevitt MR. Advances in the clinical translation of nanotechnology. Curr. Opin. Biotechnol. 46, 66–73 (2017).
  Medline CASGoogle Scholar
• 5. Mariappan N. Recent trends in nanotechnology applications in surgical specialties and orthopedic surgery. Biomed. Pharmacol. J. 12(3), 1095–1127 (2019).
  CASGoogle Scholar
• 6. Hofferberth SC, Grinstaff MW, Colson YL. Nanotechnology applications in thoracic surgery. Eur. J. Cardiothorac. Surg. 50(1), 6–16 (2016).
  MedlineGoogle Scholar
• 7. Amin K, Moscalu R, Imere A et al. The future application of nanomedicine and biomimicry in plastic and reconstructive surgery. Nanomedicine 14(20), 2679–2696 (2019).
  CASGoogle Scholar
• 8. Viswanathan VK, Manoharan SRR, Subramanian S, Moon A. Nanotechnology in spine surgery: a current update and critical review of the literature. World Neurosurg. 123, 142–155 (2019).
  MedlineGoogle Scholar
• 9. Petersen DK, Naylor TM, Halen JPV. Current and future applications of nanotechnology in plastic and reconstructive surgery. Plast. Aesthet. Res. 1, 43–50 (2014).
  Google Scholar
• 10. Chandarana M, Curtis A, Hoskins C. The use of nanotechnology in cardiovascular disease. Appl. Nanosci. 8(7), 1607–1619 (2018).
  CASGoogle Scholar
• 11. Wang DK, Rahimi M, Filgueira CS. Nanotechnology applications for cardiovascular disease treatment: current and future perspectives. Nanomedicine 34, 102387 (2021).
  Medline CASGoogle Scholar
• 12. Passaro F, Testa G, Ambrosone L et al. Nanotechnology-based cardiac targeting and direct cardiac reprogramming: the betrothed. Stem Cells Int. 2017, 4940397 (2017).
  MedlineGoogle Scholar
• 13. Flores AM, Ye J, Jarr KU et al. Nanoparticle therapy for vascular diseases. Arterioscler. Thromb. Vasc. Biol. 39(4), 635–646 (2019).
  Medline CASGoogle Scholar
• 14. Pala R, Anju VT, Dyavaiah M, Busi S, Nauli SM. Nanoparticle-mediated drug delivery for the treatment of cardiovascular diseases. Int. J. Nanomed. 15, 3741–3769 (2020).
  Medline CASGoogle Scholar
• 15. Kumar V, Palazzolo S, Bayda S, Corona G, Toffoli G, Rizzolio F. DNA nanotechnology for cancer therapy. Theranostics 6(5), 710–725 (2016).
  Medline CASGoogle Scholar
• 16. Zhang Y, Li M, Gao X, Chen Y, Liu T. Nanotechnology in cancer diagnosis: progress, challenges and opportunities. J. Hematol. Oncol. 12(1), 1–13 (2019).
  MedlineGoogle Scholar
• 17. El-Sayed A, Kamel M. Advances in nanomedical applications: diagnostic, therapeutic, immunization, and vaccine production. Environ. Sci. Pollut. Res. Int. 27(16), 19200–19213 (2020).
  Medline CASGoogle Scholar
• 18. Jin C, Wang K, Oppong-Gyebi A, Hu J. Application of nanotechnology in cancer diagnosis and therapy – a mini-review. Int. J. Med. Sci. 17(18), 2964–2973 (2020).
  Medline CASGoogle Scholar
• 19. Li J, Yao M, Shao Y, Yao D. The application of bio-nanotechnology in tumor diagnosis and treatment: a view. Nanotechnol. Rev. 7(3), 257–266 (2018).
  CASGoogle Scholar
• 20. Madhurantakam S, Babu KJ, Rayappan JBB, Krishnan UM. Nanotechnology-based electrochemical detection strategies for hypertension markers. Biosens. Bioelectron. 116, 67–80 (2018).
  Medline CASGoogle Scholar
• 21. Rudramurthy GR, Swamy MK. Potential applications of engineered nanoparticles in medicine and biology: an update. J. Biol. Inorg. Chem. 23(8), 1185–1204 (2018). • Reports on the potential use of engineered nanoparticles in medicine and biology.
  Medline CASGoogle Scholar
• 22. Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20(2), 101–124 (2021).
  Medline CASGoogle Scholar
• 23. Fenton OS, Olafson KN, Pillai PS, Mitchell MJ, Langer R. Advances in biomaterials for drug delivery. Adv. Mater. 30(29), 1705328 (2018).
  Google Scholar
• 24. Utreja P, Verma S, Rahman M, Kumar L. Use of nanoparticles in medicine. Curr. Biochem. Eng. 6(1), 7–24 (2020).
  CASGoogle Scholar
• 25. Missaoui WN, Arnold RD, Cummings BS. Toxicological status of nanoparticles: what we know and what we don't know. Chem. Biol. Interact. 295, 1–12 (2018).
  Medline CASGoogle Scholar
• 26. Gnach A, Lipinski T, Bednarkiewicz A, Rybka J, Capobianco JA. Upconverting nanoparticles: assessing the toxicity. Chem. Soc. Rev. 44(6), 1561–1584 (2015).
  Medline CASGoogle Scholar
• 27. Mahata MK, Hofsäss HC, Vetter U. Chapter 6: Photon-upconverting materials: advances and prospects for various emerging applications. In: Luminescence: an Outlook on the Phenomena and Their Applications. Thirumalai J (Ed.). BoD – Books on Demand, Goettingen, Germany (2016).
  Google Scholar
• 28. Gulzar A, Xu J, Yang P, He F, Xu L. Upconversion processes: versatile biological applications and biosafety. Nanoscale 9(34), 12248–12282 (2017).
  Medline CASGoogle Scholar
• 29. Haase M, Schäfer H. Upconverting nanoparticles. Angew. Chem. Int. Ed. Engl. 50(26), 5808–5829 (2011). •• Details upconverting nanoparticles.
  Medline CASGoogle Scholar
• 30. Chen G, Qiu H, Prasad PN, Chen X. Upconversion nanoparticles: design, nanochemistry, and applications in theranostics. Chem. Rev. 114(10), 5161–5214 (2014).
  Medline CASGoogle Scholar
• 31. Wang F, Liu X. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chem. Soc. Rev. 38(4), 976–989 (2009).
  Medline CASGoogle Scholar
• 32. Rostami I, Rezvani Alanagh H, Hu Z, Shahmoradian SH. Breakthroughs in medicine and bioimaging with up-conversion nanoparticles. Int. J. Nanomed. 14, 7759–7780 (2019). •• Reports on the potential of upconverting nanoparticles in biomedicine.
  Medline CASGoogle Scholar
• 33. Liang G, Wang H, Shi H et al. Recent progress in the development of upconversion nanomaterials in bioimaging and disease treatment. J. Nanobiotechnol. 18(1), 154 (2020).
  MedlineGoogle Scholar
• 34. Wilhelm S. Perspectives for upconverting nanoparticles. ACS Nano 11(11), 10644–10653 (2017). •• Reveals the important role of upconverting nanoparticles.
  Medline CASGoogle Scholar
• 35. Misiak M, Skowicki M, Lipiński T et al. Biofunctionalized upconverting CaF2: Yb, Tm nanoparticles for Candida albicans detection and imaging. Nano Res. 10(10), 3333–3345 (2017).
  CASGoogle Scholar
• 36. Lan J, Li L, Liu Y et al. Upconversion luminescence assay for the detection of the vascular endothelial growth factor, a biomarker for breast cancer. Microchim. Acta 183(12), 3201–3208 (2016).
  CASGoogle Scholar
• 37. Zhang X, Wang S, Cheng G, Yu P, Chang J. Light-responsive nanomaterials for cancer therapy. Engineering 13, 18–30 (2021).
  Google Scholar
• 38. Mitchell MJ, Billingsley MM, Haley RM et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101–124 (2021).
  Medline CASGoogle Scholar
• 39. Beddoes CM, Case CP, Briscoe WH. Understanding nanoparticle cellular entry: a physicochemical perspective. Adv. Colloid Interface Sci. 218, 48–68 (2015).
  Medline CASGoogle Scholar
• 40. Dror Y, Sorkin R, Brand G et al. The effect of the serum corona on interactions between a single nano-object and a living cell. Sci. Rep. 7, 45758 (2017).
  Medline CASGoogle Scholar
• 41. Akinc A, Battaglia G. Exploiting endocytosis for nanomedicines. Cold Spring Harb. Perspect. Biol. 5(11), a016980 (2013).
  MedlineGoogle Scholar
• 42. Patel S, Kim J, Herrera M, Mukherjee A, Kabanov AV, Sahay G. Brief update on endocytosis of nanomedicines. Adv. Drug Deliv. Rev. 144, 90–111 (2019).
  Medline CASGoogle Scholar
• 43. Kou L, Sun J, Zhai Y, He Z. The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J. Pharm. Sci. 8(1), 1–10 (2013).
  CASGoogle Scholar
• 44. Rennick JJ, Johnston APR, Parton RG. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nat. Nanotechnol. 16(3), 266–276 (2021).
  Medline CASGoogle Scholar
• 45. Behzadi S, Serpooshan V, Tao W et al. Cellular uptake of nanoparticles: journey inside the cell. Chem. Soc. Rev. 46(14), 4218–4244 (2017).
  Medline CASGoogle Scholar
• 46. Manzanares D, Ceña V. Endocytosis: the nanoparticle and submicron nanocompounds gateway into the cell. Pharmaceutics 12(4), 371 (2020). •• Details how nanoparticles enter cells.
  Medline CASGoogle Scholar
• 47. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu. Rev. Biochem. 78(1), 857–902 (2009).
  Medline CASGoogle Scholar
• 48. Sorkin A, von Zastrow M. Endocytosis and signalling: intertwining molecular networks. Nat. Rev. Mol. Cell Biol. 10(9), 609–622 (2009).
  Medline CASGoogle Scholar
• 49. Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J. Control. Rel. 145(3), 182–195 (2010).
  Medline CASGoogle Scholar
• 50. Oh N, Park JH. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int. J. Nanomed. 9(Suppl. 1), 51–63 (2014).
  MedlineGoogle Scholar
• 51. Zhao F, Zhao Y, Liu Y, Chang X, Chen C, Zhao Y. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 7(10), 1322–1337 (2011).
  Medline CASGoogle Scholar
• 52. Nazarenus M, Zhang Q, Soliman MG et al. In vitro interaction of colloidal nanoparticles with mammalian cells: what have we learned thus far? Beilstein J. Nanotechnol. 5(1), 1477–1490 (2014).
  MedlineGoogle Scholar
• 53. Schweiger C, Hartmann R, Zhang F, Parak WJ, Kissel TH, Rivera Gil P. Quantification of the internalization patterns of superparamagnetic iron oxide nanoparticles with opposite charge. J. Nanobiotechnol. 10(1), 28 (2012).
  Medline CASGoogle Scholar
• 54. Shang L, Nienhaus K, Nienhaus GU. Engineered nanoparticles interacting with cells: size matters. J. Nanobiotechnol. 12, 5 (2014).
  MedlineGoogle Scholar
• 55. Panariti A, Miserocchi G, Rivolta I. The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? Nanotechnol. Sci. Appl. 5, 87–100 (2012).
  Medline CASGoogle Scholar
• 56. Lynch I, Dawson KA. Protein–nanoparticle interactions. In: Nano-Enabled Medical Applications. Balogh LP (Ed.). Jenny Stanford Publishing, NY, USA, 231–250 (2020).
  Google Scholar
• 57. Mortensen NP, Hurst GB, Wang W, Foster CM, Nallathamby PD, Retterer ST. Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity. Nanoscale 5(14), 6372–6380 (2013).
  Medline CASGoogle Scholar
• 58. Brun E, Sicard-Roselli C. Could nanoparticle corona characterization help for biological consequence prediction? Cancer Nanotechnol. 5(1), 7 (2014).
  MedlineGoogle Scholar
• 59. Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S. Protein–nanoparticle interactions: opportunities and challenges. Chem. Rev. 111(9), 5610–5637 (2011).
  Medline CASGoogle Scholar
• 60. Mirshafiee V, Kim R, Park S, Mahmoudi M, Kraft ML. Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake. Biomaterials 75, 295–304 (2016).
  Medline CASGoogle Scholar
• 61. Park SJ. Protein–nanoparticle interaction: corona formation and conformational changes in proteins on nanoparticles. Int. J. Nanomed. 15, 5783–5802 (2020).
  Medline CASGoogle Scholar
• 62. Rampado R, Crotti S, Caliceti P, Pucciarelli S, Agostini M. Recent advances in understanding the protein corona of nanoparticles and in the formulation of ‘stealthy’ nanomaterials. Front. Bioeng. Biotechnol. 8, 166 (2020).
  MedlineGoogle Scholar
• 63. Palanikumar L, Al-Hosani S, Kalmouni M et al. pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics. Commun. Biol. 3(1), 95 (2020).
  Medline CASGoogle Scholar
• 64. Nam SH, Bae YM, Park YI et al. Long-term real-time tracking of lanthanide ion doped upconverting nanoparticles in living cells. Angew. Chem. Int. Ed. Engl. 50(27), 6093–6097 (2011).
  Medline CASGoogle Scholar
• 65. Li X, Tang Y, Xu L et al. Dependence between cytotoxicity and dynamic subcellular localization of up-conversion nanoparticles with different surface charges. RSC Adv. 7(53), 33502–33509 (2017).
  CASGoogle Scholar
• 66. Gu Y, Qiao X, Zhang J, Sun Y, Tao Y, Qiao S. Effects of surface modification of upconversion nanoparticles on cellular uptake and cytotoxicity. Chem. Res. Chin. Univ. 32(3), 474–479 (2016).
  CASGoogle Scholar
• 67. Guller AE, Nadort A, Generalova AN et al. Rational surface design of upconversion nanoparticles with polyethylenimine coating for biomedical applications: better safe than brighter? ACS Biomater. Sci. Eng. 4(9), 3143–3153 (2018).
  Medline CASGoogle Scholar
• 68. Guller AE, Generalova AN, Petersen EV et al. Cytotoxicity and non-specific cellular uptake of bare and surface-modified upconversion nanoparticles in human skin cells. Nano Res. 8(5), 1546–1562 (2015).
  CASGoogle Scholar
• 69. Das GK, Stark DT, Kennedy IM. Potential toxicity of up-converting nanoparticles encapsulated with a bilayer formed by ligand attraction. Langmuir 30(27), 8167–8176 (2014).
  Medline CASGoogle Scholar
• 70. Song C, Zhang S, Zhou Q et al. Bifunctional cationic solid lipid nanoparticles of β-NaYF₄:Yb,Er upconversion nanoparticles coated with a lipid for bioimaging and gene delivery. RSC Adv. 7(43), 26633–26639 (2017).
  CASGoogle Scholar
• 71. Sousa de Almeida M, Susnik E, Drasler B, Taladriz-Blanco P, Petri-Fink A, Rothen-Rutishauser B. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine. Chem. Soc. Rev. 50(9), 5397–5434 (2021).
  MedlineGoogle Scholar
• 72. Tenzer S, Docter D, Kuharev J et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 8(10), 772–781 (2013).
  Medline CASGoogle Scholar
• 73. Chen C, Li C, Shi Z. Current advances in lanthanide-doped upconversion nanostructures for detection and bioapplication. Adv. Sci. 3(10), 1600029 (2016).
  Google Scholar
• 74. Kowalik P, Elbaum D, Mikulski J et al. Upconversion fluorescence imaging of HeLa cells using ROS generating SiO₂-coated lanthanide-doped NaYF₄ nanoconstructs. RSC Adv. 7(48), 30262–30273 (2017).
  CASGoogle Scholar
• 75. Wang F, Deng R, Wang J et al. Tuning upconversion through energy migration in core–shell nanoparticles. Nature Mater. 10, 968–973 (2011).
  Medline CASGoogle Scholar
• 76. Bogdan N, Vetrone F, Ozin GA, Capobianco JA. Synthesis of ligand-free colloidally stable water dispersible brightly luminescent lanthanide-doped upconverting nanoparticles. Nano Lett. 11(2), 835–840 (2011).
  Medline CASGoogle Scholar
• 77. Sasso L, Purdie L, Grabowska A, Jones AT, Alexander C. Time and cell-dependent effects of endocytosis inhibitors on the internalization of biomolecule markers and nanomaterials. J. Interdiscip. Nanomed. 3(2), 67–81 (2018).
  CASGoogle Scholar
• 78. Sun J, Liu Y, Ge M et al. A distinct endocytic mechanism of functionalized-silica nanoparticles in breast cancer stem cells. Sci. Rep. 7(1), 16236 (2017).
  MedlineGoogle Scholar
• 79. Kuhn DA, Vanhecke D, Michen B et al. Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages. Beilstein J. Nanotechnol. 5(1), 1625–1636 (2014).
  MedlineGoogle Scholar
• 80. Liang G, Wang H, Shi H et al. Recent progress in the development of upconversion nanomaterials in bioimaging and disease treatment. J. Nanobiotechnol. 18(1), 154 (2020).
  MedlineGoogle Scholar
• 81. Zhou J, Liu Q, Feng W, Sun Y, Li F. Upconversion luminescent materials: advances and applications. Chem. Rev. 115(1), 395–465 (2015).
  Medline CASGoogle Scholar
• 82. Wang W, Gaus K, Tilley RD, Gooding JJ. The impact of nanoparticle shape on cellular internalisation and transport: what do the different analysis methods tell us? Mater. Horiz. 6(8), 1538–1547 (2019).
  CASGoogle Scholar
• 83. Ziegler A, Landfester K, Musyanovych A. Synthesis of phosphonate-functionalized polystyrene and poly(methyl methacrylate) particles and their kinetic behavior in miniemulsion polymerization. Colloid Polym. Sci. 287(11), 1261–1271 (2009).
  Medline CASGoogle Scholar
• 84. Sanità G, Carrese B, Lamberti A. Nanoparticle surface functionalization: how to improve biocompatibility and cellular internalization. Front. Mol. Biosci. 7, 587012 (2020).
  Medline CASGoogle Scholar
• 85. Thiruppathi R, Mishra S, Ganapathy M, Padmanabhan P, Gulyás B. Nanoparticle functionalization and its potentials for molecular imaging. Adv. Sci. 4(3), 1600279 (2016).
  Google Scholar
• 86. Schäfer H, Ptacek P, Eickmeier H, Haase M. Synthesis of hexagonal Yb³⁺, Er³⁺-doped NaYF₄ nanocrystals at low temperature. Adv. Funct. Mater. 19(19), 3091–3097 (2009).
  Google Scholar
• 87. Li D, Ågren H, Chen G. Near infrared harvesting dye-sensitized solar cells enabled by rare-earth upconversion materials. Dalton Trans. 47(26), 8526–8537 (2018).
  Medline CASGoogle Scholar
• 88. Li H, Xu L, Chen G. Controlled synthesis of monodisperse hexagonal NaYF₄:Yb/Er nanocrystals with ultrasmall size and enhanced upconversion luminescence. Molecules 22(12), 2113 (2017).
  MedlineGoogle Scholar
• 89. Zhou R, Ma T, Qiu B, Li X. Controlled synthesis of β-NaYF₄: yb, Er microphosphors and upconversion luminescence property. Mater. Chem. Phys. 194, 23–28 (2017).
  CASGoogle Scholar
• 90. Zajdel K, Janowska J, Frontczak-Baniewicz M, Sypecka J, Sikora B. Upconverting nanoparticles as a new bio-imaging strategy-investigating intracellular trafficking of endogenous processes in neural tissue. Int. J. Mol. Sci. 24(2), 1122 (2023).
  Medline CASGoogle Scholar
• 91. Borodziuk A, Sulowska K, Zinkiewicz Ł et al. Interaction with silver nanowires disrupts the excitation pathways in upconverting nanoparticles. Phys. Chem. C 126(45), 19219–19228 (2022).
  CASGoogle Scholar
• 92. Borodziuk A, Baranowski M, Wojciechowski T et al. Excitation efficiency determines the upconversion luminescence intensity of β-NaYF₄:Er³⁺,Yb³⁺ nanoparticles in magnetic fields up to 70 T. Nanoscale 12(39), 20300–20307 (2020).
  Medline CASGoogle Scholar
• 93. Borodziuk A, Kowalik P, Duda M et al. Unmodified rose bengal photosensitizer conjugated with NaYF₄:Yb,Er upconverting nanoparticles for efficient photodynamic therapy. Nanotechnology 31(46), 465101 (2020).
  Medline CASGoogle Scholar
• 94. Augustine R, Hasan A, Primavera R, Wilson RJ, Thakor AS, Kevadiya BD. Cellular uptake and retention of nanoparticles: insights on particle properties and interaction with cellular components. Mater. Today Commun. 25, 101692 (2020).
  CASGoogle Scholar
• 95. Jin J, Gu YJ, Man CW et al. Polymer-coated NaYF₄:Yb³⁺,Er³⁺ upconversion nanoparticles for charge-dependent cellular imaging. ACS Nano 5(10), 7838–7847 (2011).
  Medline CASGoogle Scholar
• 96. Soenen SJ, Parak WJ, Rejman J, Manshian B. (Intra)cellular stability of inorganic nanoparticles: effects on cytotoxicity, particle functionality, and biomedical applications. Chem. Rev. 115(5), 2109–2135 (2015).
  Medline CASGoogle Scholar
• 97. Chen M, Zeng G, Xu P, Lai C, Tang L. How do enzymes ‘meet’ nanoparticles and nanomaterials? Trends Biochem. Sci. 42(11), 914–930 (2017).
  Medline CASGoogle Scholar
• 98. Francia V, Reker-Smit C, Boel G, Salvati A. Limits and challenges in using transport inhibitors to characterize how nano-sized drug carriers enter cells. Nanomedicine 14(12), 1533–1549 (2019).
  CASGoogle Scholar
• 99. Degors IMS, Wang C, Rehman ZU, Zuhorn IS. Carriers break barriers in drug delivery: endocytosis and endosomal escape of gene delivery vectors. Acc. Chem. Res. 52(7), 1750–1760 (2019).
  Medline CASGoogle Scholar
• 100. Dutta D, Donaldson JG. Search for inhibitors of endocytosis: intended specificity and unintended consequences. Cell Logist. 2(4), 203–208 (2012).
  MedlineGoogle Scholar
• 101. Tsai ES, Joud F, Wiesholler LM, Hirsch T, Hall EAH. Upconversion nanoparticles as intracellular pH messengers. Anal. Bioanal. Chem. 412(24), 6567–6581 (2020).
  Medline CASGoogle Scholar
• 102. Dutta D, Williamson CD, Cole NB, Donaldson JG. Pitstop 2 is a potent inhibitor of clathrin-independent endocytosis. PLOS ONE 7(9), e45799 (2012).
  Medline CASGoogle Scholar
• 103. Sikora B, Kowalik P, Mikulski J et al. Mammalian cell defence mechanisms against the cytotoxicity of NaYF₄:(Er,Yb,Gd) nanoparticles. Nanoscale 9(37), 14259–14271 (2017).
  Medline CASGoogle Scholar
• 104. Bae YM, Park YI, Nam SH et al. Endocytosis, intracellular transport, and exocytosis of lanthanide-doped upconverting nanoparticles in single living cells. Biomaterials 33(35), 9080–9086 (2012).
  Medline CASGoogle Scholar
• 105. Samhadaneh DM, Mandl GA, Han Z et al. Evaluation of lanthanide-doped upconverting nanoparticles for in vitro and in vivo applications. ACS Appl. Bio Mater. 3(7), 4358–4369 (2020).
  Medline CASGoogle Scholar
• 106. Wang C, He M, Chen B, Hu B. Study on cytotoxicity, cellular uptake and elimination of rare-earth-doped upconversion nanoparticles in human hepatocellular carcinoma cells. Ecotoxicol. Environ. Saf. 203, 110951 (2020).
  Medline CASGoogle Scholar
• 107. Ferrera-González J, Francés-Soriano L, Galiana-Roselló C et al. Initial biological assessment of upconversion nanohybrids. Biomedicines 9(10), 1419 (2021).
  Medline CASGoogle Scholar
• 108. Shen H, Lin Q, Cao W et al. Efficient and long-lifetime full-color light-emitting diodes using high luminescence quantum yield thick-shell quantum dots. Nanoscale 9(36), 13583–13591 (2017).
  Medline CASGoogle Scholar
• 109. Yu Y, Huang T, Wu Y, Ma X, Yu G, Qi J. In-vitro and in-vivo imaging of prostate tumor using NaYF₄: Yb, Er up-converting nanoparticles. Pathol. Oncol. Res. 20(2), 335–341 (2014).
  Medline CASGoogle Scholar
• 110. Zhou M, Ge X, Ke DM et al. The bioavailability, biodistribution, and toxic effects of silica-coated upconversion nanoparticles in vivo. Front. Chem. 7, 218 (2019).
  Medline CASGoogle Scholar
• 111. Lakshmanan A, Akasov RA, Sholina NV et al. Nanocurcumin-loaded UCNPs for cancer theranostics: physicochemical properties, in vitro toxicity, and in vivo imaging studies. Nanomaterials 11(9), 2234 (2021).
  Medline CASGoogle Scholar
• 112. Chatterjee DK, Rufaihah AJ, Zhang Y. Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials 29(7), 937–943 (2008).
  Medline CASGoogle Scholar
• 113. Nordmann J, Buczka S, Voss B, Haase M, Mummenhoff K. In vivo analysis of the size- and time-dependent uptake of NaYF₄:Yb,Er upconversion nanocrystals by pumpkin seedlings. J. Mater. Chem. B 3(1), 144–150 (2015).
  Medline CASGoogle Scholar
• 114. Yin W, Zhou L, Ma Y et al. Phytotoxicity, translocation, and biotransformation of NaYF₄ upconversion nanoparticles in a soybean plant. Small 11(36), 4774–4784 (2015).
  Medline CASGoogle Scholar